Crescent Star Insurance Co. Ltd.PSX: CSIL

Revised Final Right Offer Document for Shareholders as per SECP Written Comments

· MarketScreener


Estd. 1957

January 20, 2026

The General Manager

Pakistan Stock Exchange Limited Stock Exchange Building

Stock Exchange Road Karachi

Subject: REVTSED FINAL RIGHT OFFER DOCUMENT FOR SHAREHOT DERS AS PERSECP WRITTENCOMMENTS

Dear Sir,

We are enclosing herewith the Revised Final Right Offer Document, wherein all comments received from Pakistan Stock Exchange and Securities and Exchange Commission of Pakistan (SECP) have been duly incorporated. The comments along with their respective compliances have been appropriately disclosed in the Offer Document.

In compliance with the applicable provisions of the PSX Regulations, the Revised Final Right Offer Document is enclosed herewith and may kindly be disseminated.

For an on behalf of

Crescent tar Insurance Limited

Malik elidi M ammad

Chief Financial Officer/Company Secretary

Head Office: 2nd Floor, Nadir House, I.I Chundrigar Road, Karachi - 74000, Pakistan

UAN : +92-21-111-274-000 PABX: +92-21-32415471-3 Fax : +92-21-32415474 E-mail : info@cstarinsurance.com

  1. ADVISE FOR INVESTORS

    1. INVESTMENT IN EQUITY SECURITIES AND EQUITY RELATED SECURITIES INVOLVES A CERTAIN DEGREE OF RISKS. THE INVESTORS ARE REQUIRED TO READ THE RIGHTS SHARE OFFER DOCUMENT (HEREIN REFERRED TO AS 'OFFER DOCUMENT') AND RISK FACTORS CAREFULLY, ASSESS THEIR OWN FINANCIAL CONDITIONS AND RISK-TAKING ABILITY BEFORE MAKING THEIR INVESTMENT DECISIONS IN THIS OFFERING.

      RIGHT ENTITLEMENT LETTER IS TRADABLE ON PSX, RISKS AND REWARDS ARISING OUT OF IT SHALL BE SOLE LIABILITY OF THE INVESTORS.

    2. THIS DOCUMENT IS ISSUED FOR THE PURPOSE OF PROVIDING INFORMATION TO SHAREHOLDERS OF THE COMPANY AND TO THE PUBLIC IN GENERAL IN RELATION TO THE RIGHTS ISSUE OF PKR 122,772,348 (ONE HUNDRED TWENTY TWO MILLION SEVEN HUNDRED SEVENTY TWO THOUSAND THREE HUNDRED FORTY EIGHT ONLY) CONSISTING OF (40,924,116) NEW ORDINARY SHARES OF PKR 3/- EACH BY CRESCENT STAR INSURANCE. A COPY OF THIS DOCUMENT HAS BEEN REGISTERED WITH THE SECURITIES EXCHANGE.

      THIS OFFER DOCUMENT IS VALID TILL APRIL 14, 2026.



    3. Your Securi Our Policy

      Crescent Star Insurance Limited Right Share - Offer Document

      Office: 2'd Floor, Nadir House, I.I. Chundrigar Road Karachi, 74000, Pakistan, Contact Details: Phone

      + 92 021 32415471, Email: danish.rizvi@cstarinsurance.com, Website: www.cstarinsurance.com, Contact PerSon: Syed Danish Hasan Rizvi Senior Manager, Date of Incorporation: May 8, 1957, Place of Incorporation Karachi, Company Registration No.: 0000870, Share Registrar: FD registrar Suit 1705 - A. 17th Floor, Saima Trade Tower, I.I Chundrigar Rd, Saddar Karachi - 74400, Tel: (92-21) 32415471-74. Email: info@cstarinsurance.com, website: www.cstarinsurance.com

    4. Circular under Section 83(3) of the Companies Act, 2017 and Schedule 1 under the Companies (Further Issue of Shares) Regulations, 2020 for issue of 40,924,116 (Forty million Nine hundred Twenty Four thousand One hundred Sixteen only) ordinary shares by way of Rights (i.e. 38%, of the existing paid-up capital of Crescent Star Insurance Limited) at an offer price of PKR 3/- per share (i.e. at discount of PKR 7/- (Pak Rupees Seven) to par for an aggregate issue size of PKR 122,772,348 (One hundred Twenty Two million Seven hundred Seventy Two thousand Three hundred Forty Eight only). at a ratio of 38 rights shares for every 100 shares held.

    5. & (vi)

      Date of placin'g offer document on PSX for Public

      Comments

      Not opted for Public comments

      Date of 'Final Offer Letter

      January 12, 2026

      Date of Book Closure

      January 20, 2026

      Dates for Pav+entof Subscription Amounts

      January 22, 2026 to February 13, 2026

      Trading Dates for Letter of Rights

      January 22, 2026 to February 6, 2026

      .Website address to download Offer Document

      https://www.cstarinsurance.com

      1. Details of Relevant Contact Person

        Description

        Name of Person

        Designation

        Contact Number

        Office Address

        Email ID

        Authorize

        Mr. Syed

        Senior

        +92 21

        2nd Floor Nadir

        danish.rizvi@cstarinsurance.

        d Officer of the Issuer

        Danish Hasan Rizvi

        Manager

        32415471

        House, I.I. Chundrigar Road-74000

        com

        Underwriters:

        Underwriter

        Name of Person

        Designation

        Contact Number

        Office Address

        Email ID

        Dawood

        Equities Limited

        Mr. Abdul

        Aziz Habib

        Chief

        Executive Officer

        021-

        32271881

        Saima Trade

        Tower A, 17t Floor, I.I.

        Chundrigar

        contact@dawoodequities.com

        Road,

        Karachi

        Bankers to the issue:

        Description

        Name of Person

        Designation

        Contact Number

        Office Address

        Email ID

        Faysal

        Bank Limited

        Zohaib Ali

        Khan

        RM

        +9221-

        32418485

        IBB l.l.

        Chundrigar II Branch, Karachi

        Zohaibalikhan@faysalbank.com

      2. This Offer Document can be downloaded from https://cstarinsurance.com/investors-relations/





        RtlPEE8



        P Y Date of Issue: STAñtP VENDOR Paper Issued to:

        02-01-2026



        Kashif Nazeer Adv (Ledger No.23868]

        GoS-KHI-47

        Shop No. L-11, Jinnah

        Square, Malir, Karachi.

        Address: Contact No. Purpose: Challan No. Date:

        Karachi

        0000-00000000



        Bond

        20258256F3FC114F

        26-12-2025

        / s Q t / T Q .. .. w ... . .+ .-. - . . - --- -- - -•- •- - *-•• --• -°- - -

        You can verify your Stamp paper by scanning the QR code or online wk.estamps.gos.pk by using the "Verification Through Web" option before purchased.

  2. ISSUER UNDERTAKING



    UN ERTA NG Y H H UT E OFF ER AN CH EF NANC AL C





    WE, THE UNDERSIGNED OF CRESCENT STAR INSURANCE LIMITED CERTIFY THAT;

    1. THIS OFFER DOCUMENT CONTAINS ALL INFORMATIOWNITH REGARD TO THE ISSUER AND THE ISSUE, WHICH IS MATERIAL IN THE CONTEXT OF THE ISSUE AND NOTHING HAS BEEN CONCEALED

      IN THIS RESPECT;



    2. THE INFORMATION CONTAINED IN THE OFFER DOCUMENT ISTRUE AND CORRECT TO THE BEST OF OUR KNOWLEDGE AND BELIEF;

    3. THE OPINIONS AND INTENTIONS EXPRESSED THEREIN ARE HONESTLY HELD;



    4. THERE ARE NO OTHER FACTS, THE OMISSION OF WHICH MAKES THE OFFER DOCUMENT AS A WHOLE OR ANY PART THEREOF MISLEADING; AND

    V. ALL REQUIREMENTSOF THE COMPANIES ACT, 2017, THE COMPANIES (FURTHER ISSUE OF SHARES) REGULATIONS, 2020, THE CENTRAL DEPOSITORY COMPANY AND THAT OF PSX PERTAINING TO THE RIGHT ISSUE HAVE BEEN FULFILLED.

    FOR AND BEHALF OF CRESCENT STAR INSURANCELIMITED

    Mr. alik ehdi Muhammad Chief Financial Officer

    Mr. Nairn Anwar

    Chief Executive Officer



    AE 8 7 0 416

    ONE HUNDRED RUPEES

    100

    Rupees





    Sale Register Serial No. 80216

    MUHAMMAD RAFAY

    STAMP VENDOR

    Date of Issue:

    Paper Issued to:

    02-01-2026

    Kashif Nazeer Adv [Ledger No.23868]

    GoS-KHI-47 Address:

    Karachi

    Shop No. L-11, Jinnah Square, Malir, Karachi.

    Contact No. Purpose: Challan No. Date:

    0000-00000000



    Bond

    20258256F3FC114F

    26-12-2025

    n ve fy you Sta p paper by scanning the QR d I

    ou

    I his Line

    p p u n the Ve cat on Th u h Web pt n befo e u cha ed

  3. UNDERTAKING BY BOARD OF DIRECTORS

    We, the board of directors of Crescent Star Insurance Limited hereby confirm that:



    1. All material information as required under the Companies Act, 2017, the Securities Act, 2015, Companies (Further lssue of Shares) Regulations, 2020, the listing of Companies and Securities regulations of the Pakistan Stock Exchange Limited has been disclosed in this offer document and that whatever is stated in offer document and in the supporting documents is true and correct to the best of our knowledge and belief and that nothing has been concealed.

    2. We undertake that all material information, including risks that would enable the investor to

      make an informed decision, has been disclosed in the offer document.

    3. Right issue has been approved by the Board, General Body and approval of the Commission to issue right shares at discount was received on September 23, 2025.



    4. The draft offer document was placed on the website of Securities Exchange and the issuer on October 1, 2025.

    5. Comments from Securities Exchange and SECP were received on October 23, 2025 and January 19, 2026 respectively.

    6. The Board has ensured that draft offer document is updated in light of Securities Exchange and SECP

      comments.

    7. The Board has disclosed on PSX and Company's website, all the comments received along with the explanations as to how they are addressed.



    8. The final offer document was submitted to the Commission and placed on Securities Exchange website on January 20, 2026 along with the book closure dates and relevant right issuance timelines. (i.e. within 5 working days from the date of receipt of comments of PSX and SECP).

    9. The statutory auditor M/s Naveed Zafar Ashfaq Jaffery & Co., Chartered Accountants of the issuer shall submit half yearly report to the issuer regarding utilization of proceeds in the manner referred to in the final offer document. The issuer will include the report of the statutory auditor, along with its comments thereon, if any, in its half yearly and annual financial statements.

    10. The issuer has complied with the requirements of section 82 of the Companies Act, 2017 with provisions of issuance of right shares at discount to face value.



    11. There was no dissenting vote in the meeting held on March 27, 2025 in which right shares were recommended by the Board.

    For arl beha f of Crescent Star Insurance Limited

    Mehdi Muhammad

    Mr. Nairn nwar



    Chief Financial Officer Chief Executive Officer

  4. DISCLAIMER

    In line with the Companies Act, 2017 and Companies (Further Issue of Shares) Regulations, 2020, this document does not require approval of the Securities Exchange and the Securities and Exchange Commission of Pakistan (SECP).

    The Securities Exchange and the SECP disclaim:

    1. Any liability whatsoever for any loss however arising from or in reliance upon this document to anyone, arising from any reason, including, but not limited to, inaccuracies, incompleteness and/or mistakes, for decisions and/or actions taken, based on this document.

    2. Any responsibility for the financial soundness of the Company and any of its schemes/projects stated herein or for the correctness of any of the statements made or opinions expressed with regards to them by the Company in this Offer document.

    3. Any responsibility with respect to the quality of the issue.

    It is clarified that information in this Offer document should not be construed as advice on any particular matter by the SECP and the Securities Exchange and must not be treated as a substitute for specific advice.

  5. GLOSSARY OF TERMS & DEFINITIONS

    BoD

    Board of Directors

    Company or Issuer

    Crescent Star Insurance Limited

    Companies Act

    Companies Act, 2017

    CDC

    Central Depository Company of Pakistan Limited

    CDS

    Central Depository System

    PKR or Rs

    Pakistani Rupees

    PSX or Securities

    Exchange

    Pakistan Stock Exchange Limited

    SECP or Commission

    Securities & Exchange Commission of Pakistan

  6. DEFINITIONS

    ›Bafike







    i/ . e

    Or







    Any bank with whom an account is opened and maintained by the Issuer for) keeping the issue amount.

    Faysal Bank Limited has been appointed as Bankers to the Issue, in this Right

    lssue.



    The Book Closure is on January 2O, 2026.

    lssue of 40,924,116 right shares representing 38% of the total paid-up capital of the Company.

    The price at which right shares of the Compa'ny are offered to the existing shareholders.

    The latest available closing price of the share. Total assets minus total liabilities.

    OKR y Shhres of Crescent Star Insurance Limited having face value ot

    f2

    The Companies (Further Issue of Shares) Regulations, 2020

    h t s sec o k d cu ent he co an e ur her ssue o shares re ulatio s 202 u dated arch 4 2024/?wpdmdI=51188&refresh=666abc0e1d7e01718270990

    e ' trictly in propor ion to the)

    Shared alre addhbdan* e n ve kindsae bas ses

    A person who has contrbuted initial capital in the issuing company or has the' right to appoint majority of the directors on the board of the issuing company directly or indirectly;

    A person who replaces the person referred to above; and A person or group)

    of persons who has control of the issuing company whether directly oq





    indirectly.

    """ """"""""""" """"""""""""""""""""" """""""""""" " """"""" "" """""""""""""""!

    CONTENTS

    1. SALIENT FEATURES OF THE RIGHT ISSUE. 08

    2. Brief Terms of the Rights lssue 08

    3. Principal Purpose of the Issue and funding arrangements 09

    4. Financial Effects Arising from Right lssue 10

    5. Total expenses to the issue. 10

    6. Details of Underwriters 10

    7. Commitments from substantial shareholders/directors 10

    8. Fractional Rights Shares 10

    9. Important Dates 11

    10. Subscription Amount Payment Procedure 11

    11. Profile of Board of Directors of The Company And Sponsors 11

    12. Profile of the Board of Directors of the Company 12

    13. Profile of the Company 14

    14. Financial Details of The Issuer. 15

    15. Financial highlights of Issuer for last three years 15

    16. Financial highlights for the preceding year of consolidated financial 16

    17. Detail of issue of capital in previous five years 16

    18. Average market price of the share of the Issuer during the last six months 16

    1g.

    20.

    21.

    22.

    23.

    24.

    25.

    Share Capital and Related Matters 16

    Risk Factors 18

    Risk Associated with the rights issue. 18

    Risk Associated with the issuer. 19

    External Risk Factors 19

    Legal Proceedings 20

    Outstanding Legal Proceedings of the Company 20

    1. Action taken by the Securities Exchange against the issuer or associated listed companies of the Issuer during the last three years due to noncompliance of

      the its Regulations 20

    2. Any outstanding legal proceeding other than the normal course of business involving the Issuer, its sponsors, substantial shareholders, directors and associated companies, over which the issuer has control, that could have

      material impact on the issue 21

    3. Signatories To The Offer Document. 21

  7. SALIENT FEATURES OF THE RIGHT ISSUE

  1. Brief Terms of the Rights Issue:

    a)

    Description of issue

    Issuance of new ordinary shares by way of rights to existing shareholders of the Company, at PKR 3/- (Pak Rupees Three only) per share, as per their proportional entitlement.

    b)

    Size of the proposed issue

    The Company shall issue 40,924,116 (Forty million Nine hundred Twenty

    Four thousand One hundred Sixteen only) ordinary shares, at a price of PKR 3/- (Pak Rupees Three only) per share, aggregating to PKR 122,772,348 (One hundred Twenty Two million Seven hundred Seventy Two thousand Three hundred Forty Eight only).

    )

    Face value of the share

    R 10/- each

    d)

    Basis of determination of

    price of the Right lssue

    The Right Issue is being carried out at a discount of PKR 7/- (Pak Rupees

    Seven) to par. Considering the market price (PKR 2.68 per share) as on the date of announcement of Right (March 27, 2025) and the 90 days average price of PKR 2.9 per share preceding the announcement, the

    issue price at discount of PKR 7 to par is justified.

    e)

    Proportion of new issue to

    existing with condition, if any

    38 Right shares for every 100 ordinary shares held by existing

    shareholders.

    f)

    Date of meeting of the BOD

    wherein the Right Issue was approved

    March 27, 2025

    g)

    Names of directors attending the BOD meeting

    h)

    Rrief purpose of utilization of Right Issue proceeds

    The proceeds from the Right Issue will be primarily utilized for meeting working capital requirements and to expand the insurance business of the company which includes marketing and digitization of insurance products.

    i)

    Purpose uf the Right Issue -

    Details of the main objects for raisi'ng funds through present Right Issue

    As given below.

    j)

    Minimum level of

    subscription (MLS)

    Not Applicable

    k)

    "Application Supported by

    Blocked amount" (ASBA) facility, if any, will be provided for subscription of right shares.

    Not Opted

    1. Mr. Nairn Anwar - CEO

    2. Mr. Suhail Elahi

    3. Ms. Naveeda Mahmud

    4. Ms. Huma Javaid

    5. Ms. Rabia Omar Hassan

  2. Principal Purpose of the Issue and funding arrangements:

    The principal purpose of the Right lssue is to further strengthen the Company's capital base and solvency position in order to support sustainable growth and compliance with regulatory capital requirements as well as to expand the insurance business of the company including marketing and digitization of insurance products. The enhanced paid-up capital will enable the Company to expand its underwriting capacity, increase its retention limits, and obtain more favorable terms from reinsurers and financial institutions. This capital strengthening is a key element of the Company's long-term strategy to reinforce financial resilience, improve creditworthiness, and enhance its competitive position in the insurance sector.

    As an insurance company, the proceeds from the Right Issue will have two complementary aspects. Firstly the Right Issue will ensure compliance with the enhanced paid-up capital requirements prescribed by the regulator but will also position the Company to capitalize on future growth opportunities, improve operational stability, compliment company's investment portfolio in accordance with its approved Investment policy to achieve optimal risk-adjusted returns. This will increase investment income, thereby contributing to the Company's profitability and overall financial performance and deliver higher and more sustainable returns to shareholders. The capital infusion will directly enhance the Company's equity base and solvency margins, ensuring greater financial flexibility and the ability to underwrite larger risks while maintaining prudent risk management practices. Secondly, will enable the company to expand the insurance business of the company including marketing and digitization of insurance products.

    Purpose of the Issue*

    Amount (PKR)

    % of Right Issue Proceeds

    Strengthen capital base

    PKR 122,772,348/-

    100'X0

    Increase level of retention

    Adherence to revised SECP's Paid- up

    Capital Requirements

    Investment in Securities

    Securing better reinsurance treaty

    capacity and price

    Improved financial strength rating

    Marketing and digitization of insurance

    products

    *Note: The Company is in the business of insurance and it merits mentioning that there is no separate allocation of amount from the capital for the purposes of increasing its net retention, obtaining reinsurance terms, having better insurer financial strength rating in respect of improved solvency that is achieved by keeping the proceeds in assets which are admissible assets under the framework and marketing and digitizing of insurance products. However, as per the requirement of the Regulations, the disclosure as appropriate has been made.

  3. Financial Effects Arising from Right Issue:



    As at 30 June 2025

    Measurement Unit Shares

    Pre-lssue

    Post-lssue

    Increase in

    Percentage

    Shares

    115,000,000

    150,000,000

    30%

    Shares

    107,695,041

    148,619,157

    38%

    Net Assets Breakup value per

    share

    PKR

    11.94

    11.40

    0.54

    Gearing Ratio

    %

    19

    14

    (24%)

    Production Capacity

    N/A

    N/A

    N/A

    N/A

    Market Share

    N/A

    N/A

    N/A

    N/A

    *Form 7 for increase in authorized capital from PKR 115 million to PKR 150 million has been filed and accepted by CRO.

    Right shares are being issued at a discount of PKR 7 to par that is at PKR 3 per share. Approval from SECP was received on 23-09-202S.

  4. Total expenses to the issue:

    Underwriting Commission 1%

    Bankers Commission 0.5%

    PSX Fee (0.2% of increase in paid-up-capital Upto PKR 8S0,000

    SECP Supervisory Fee (10% of fees paid to PSX) Upto PKR 8S,000

    CDC Fee - Fresh Issue Fee 0.144% of the new share capital Stamp Duty for Additional Shares 0.15% of face value in book entry form Upto PKR 650,000

    1.5% on physical shares

    Auditor Fee for Auditors Certificates (M/s Naveed Zafar Ashfaq Jaffery & Co.) Upto PKR S00,000

    Other expenses (including printing costs, lawyers (AHM & Co.) and consultation fees, etc.)

    Upto PKR 2,000,000





  5. Details of Underwriters:

    Name of Underwriter

    Dawood Equities Limited

    Amount Underwritten (PKR) Associated Company/Associated

    undertaking of Issuer (Yes/No)

    111,140,769 No

  6. Commitments from substantial shareholders/directors:

    Name of Person

    Status

    (Substantial Shareholder/Di rector

    Number of

    Shares Committed to be

    Subscribe*

    Amount

    Committed to be Subscribed

    (PKR)*

    Shareholding

    % pre-issuance

    7.54%

    Shareholding

    % post-issuance*

    33°

    Weavers Pakistan (Pvt.) Limited (WPL)

    - "

    4,262,891

    12,788,673

    ""*Including through persons arranged by such substantial shareholders/ directors WPL shall subscribe the unsubscribed portion of directors and promoters.

  7. Fractional Rights Shares:

    Fractional entitlements, if any, shall not be offered and all fractions less than a share shall be consolidated and disposed of by the company and the proceeds from such disposition shall be paid to such of the entitled shareholders as may have accepted such offer within fifteen days after completion of allotment.

  8. Important Dates:

Crescent Star Insurance Limited



Tentative Schedule for Issuance of Letter of Rights

S.No.

Procedure

Day

Date

1

Credit of Unpaid Rights into CDC in Book Entry

Wednesday

January 21, 2026

2

Dispatch of Letter of Right (LOR) to

physical shareholders

Friday

January 23, 2026

3

Intimation to Stock Exchange for

dispatch/credit Of Dhvsical Letter of

Friday

January 23, 2026

4

Commencement of trading of unpaid Rights

on Pakistan Stock Exchange Limited

Thursday

January 22, 2026

5

Last date for splitting and deposit of Requests

Tuesday

January 27, 2026

6

Last date of trading of Letter of Rights

Friday

February 6, 2026

7

Last date for acceptance of payment

Friday

February 13, 2026

8

Allotment of shares and credit of Shares into

Friday

February 27, 2026

9

Date of dispatch of physical shares certificates

Friday

February 27, 2026

(§



(iv)

(v)

  1. SUBSCRIPTION AMOUNT PAYMENT PROCEDURE

    Payment as indicated above should be made by cash or crossed cheque or demand draft or pay order made out to the credit of "Crescent Star Insurance Limited-Right Shares Subscription Account" through any of the authorized branches of above-mentioned bank(s) on or before February 13, 2026 along with this Right Subscription Request duly filled in and signed by the subscriber(s).

    Right Subscription Request can be downloaded from the Company website www.cstarinsurance.com.

    In case of Non-Resident Pakistani / Foreign shareholder, the demand draft of the equivalent amount in Pak Rupees should be sent to the Senior Manager, (Mr. Syed Danish Hasan Rizvi) at the office of the issuer along with Right Subscription Request (both copies) duly filed and signed by the subscriber(s) with certified copy of NICOP / Passport well before the last date of payment.

    All cheques and drafts must be drawn on a bank situated in the same city where the Right Subscription Request is deposited. Cheque is subject to realization.

    The Banker(s) to the Issue will not accept Right Subscription Requests delivered by post which may reach after the closure of business February 13, 2026 unless evidence is available that these have been posted before the last date of payment.

    Payment of the amount indicated above to the Issuer's Banker(s) to the Issue on or before February 13, 2026 shall be treated as acceptance of the Right offer.

    After payment has been received by the Banker(s) to the Issue, the Right Securities will be credited into respective CDS Accounts within 14 business days from the last payment date. Paid Right Subscription Request will not be traded or transferred.

  2. PROFILE OF BOARD OF DIRECTORS OF THE COMPANY AND SPONSORS



    Name

    Position

    Tenure of Directorship

    Mr. Nairn Anwar

    Director & Chief Executive Officer

    Since APriI 28, 2023

    Mr. Suhail Elahi

    Executive Director

    Since April 28, 2023

    Ms. Komal Lodhi

    Executive Director

    Since March 26, 2025

    Mr. Shaikh Waqar Ahmed

    Independent Director

    Since April 28, 2023

    IVIs. Naveeda Mahmud

    Independent Director

    Since April 28, 2023

    Ms. Huma Javaid

    Independent Director

    Since Agril 28, 2023

    Mr. Rashid Malik

    Non- Executive Director

    Since April 28, 2023

    Ms. Rabia Omer Hassan

    Non- Executive Director

    Since ADriI 28, 2023

    Profile of the Board of Directors of the Company MR. NAIM ANWAR

    Director & Chief Executive Officer - SINCE 2013

    Mr. Nairn Anwar brings with him over 40 years of professional experience, including more than 30 years in senior roles within the insurance sector. He has held key leadership positions at Adamjee Insurance Ltd. as Executive Director and PICIC Insurance Ltd. as Deputy Managing Director, before assuming the role of Managing Director & CEO at Crescent Star Insurance Limited (CSIL) in 2013.

    As a Board Member, Mr. Anwar plays a pivotal role in guiding CSlL's strategic direction, corporate governance, and long-term growth agenda. His deep industry knowledge spans sales, operations, reinsurance, underwriting & claims, risk management, and corporate affairs.

    He has actively contributed to the development of Pakistan's insurance sector, serving on the Executive Committee and Technical Committees of the Insurance Association of Pakistan (IAP), including a term as Vice Chairman, and as Chairman of the Pakistan Insurance Institute (PII). With an ACCA background, hé is a graduate of the Government College of Commerce & Economics, Karachi, a Certified Director from ICMA, and an alumnus of INSEAD Business School, Singapore (Leadership for Results Program)

    Directorships in other Companies

    • Crescent Star Insurance Limited.

    • Crescent Star Foods (Pvt.) Limited.

    • Crescent Star Luxury (Pvt.) Limited.

    • Crescent Star Technology (Pvt.) Limited.

    • Dost Steels Limited.

    • Bawany Air Products Limited.

      MR. SUHAIL ELAHI

      Director - SINCE 2019

      Mr. Suhail Elahi serves as Resident Director and Member of the Board of Directors at CSIL. Based at the Regional Office North in Lahore, he provides strategic oversight of the company's Northern operations while contributing to CSlL's governance framework at the Board level.

      With extensive experience in Pakistan's textiles and leather industries and exposure to international markets, Mr. Elahi brings a broad business perspective to the Board. Since joining CSIL in 2016, he has overseen the Travel Insurance portfolio and has represented the company in entities where CSIL maintains strategic investment

      interests.

      As a Board Member, Mr. Elahi contributes to shaping CSlL's corporate strategy and governance practices, combining his operational leadership with'insights from his diverse industry background.

      Directorships in other Companies

    • Dost Steels Limited.

    • Bawany Air Products Limited.

      MRS. KOMAL LODHI

      Director - SINCE 2025

      Ms. Komal Lodhi serves as a Director on the Board of Crescent Star Insurance Limited (CSIL). An MBA in Marketing, she brings a strong business development focus to the company's strategic direction.

      She has been associated with CSIL for over six years, where she successfully set up and managed the Alternate Distribution Channel, introducing modern-age selling platforms and enhancing the company's reach in new segments. Her entrepreneurial drive and innovative approach have contributed significantly to the growth of CSIL's Travel Insurance portfolio.

      Her inclusion on the Board also marks an important milestone for CSIL, taking the company to a 50/50 gender-balanced Board - a distinction that is rare among listed companies on the Pakistan Stock Exchange. This reflects CSIL's commitment to diversity, inclusivity, and progressive governance.

      MR. SHAIKH WAQAR AHMED

      Director - SINCE 2023

      Mr. Shaikh Waqar Ahmed is a seasoned corporate professional with over 34 years of experience in both local and multinational organizations, spanning the IT, petroleum, consumer durables, and port & shipping sectors. His career has equipped him with rich expertise in sales, customer service, human resources, and organizational development.

      He holds a Master of Business Administration (MBA) from the Institute of Business Administration (IBA), Karachi, and further enhanced his leadership credentials by completing the Management Development Program at the University of Houston, USA, on a USAID scholarship. In addition, he is a Certified Trainer of Trainers, reflecting his commitment to professional development and knowledge sharing.

      Over his career, Mr. Ahmed has held senior roles at Jaffer Brothers, Dawlance, KFC, KCITL, and culminated his corporate journey with a senior management role at Pakistan Petroleum Limited (PPL) before retiring in 2017. He continues to serve as a trusted advisor to the corporate sector, leveraging his vast experience to guide businesses in strategy and organizational growth.

      As a Director on the Board of CSIL, he contributes his broad-based corporate expertise and governance experience, adding depth to the company's leadership and strategic decision-making.

      MRS. NAVEEDA MAHMUD

      Director - SINCE 2023

      Ms. Naveeda Mahmud is a senior HR and management professional with over 35 years of diversified experience across marketing, human resource management, training, and organizational development. An MBA graduate from the Institute of Business Administration (IBA), Karachi, she brings a strong combination of strategic insight and people management expertise to the Board of Crescent Star Insurance Limited (CSIL).

      She spent 12 years with Pakistan International Airlines (PIA), contributing to marketing, research, planning, commercial agreements, and management training. She later served as National Manager HR at DHL Pakistan, and as Senior Manager Training & Development at Pakistan Petroleum Limited (PPL), where she was instrumental in designing and delivering capacity-building initiatives.

      Ms. Mahmud also held the position of Executive Director at the Pakistan Insurance Institute (PII), where she worked to strengthen professional standards and training within the insurance sector. At CSIL, she brings her wealth of knowledge and leadership experience to the Boardroom, adding value through her expertise in organizational development, governance, and human capital strategy.

      M'RS. HUMA JAVAID

      Director - SINCE 2023

      Ms. Huma Javaid is a senior HR professional with over 15 years of experience across diverse areas of human resource management. She is currently serving as Head of Human Resources - Commercial at Manin Dow Ltd, where she leads HR strategy and execution, ensuring alignment with business goals and sustainable talent development.

      She began her career with Adamjee Insurance Ltd., where she gained extensive exposure to the human resource needs of the insurance sector, with a specialized focus on developing and managing insurance professional talent. Over the years, she has built expertise in organizational culture, talent acquisition, employee engagement, and HR strategy.

      At CSIL, Ms. Javaid contributes to the Board's oversight of human capital and organizational development, offe'ring valuable guidance to C-level leadership on decisions impacting people and culture. Her focus on building a vibrant, healthy, and performance-driven workplace ensures that CSIL continues to prioritize its most valuable asset - its people.

      Directorships in other Companies

      • Hafiz Limited.

    MR. RASHID MALIK

    Director - SINCE 2023

    Mr. Rashid Malik is a seasoned professional with over 31 years of marketing and business experience, with a strong background in international trade and supply chain management. Based in Canada, he has established long-standing relationships with leading global equipment manufacturers, enabling him to act as a direct link between international suppliers and local businesses in Pakistan.

    He has been closely associated with supplying restaurant and food service equipment to various major food chains in Pakistan, leveraging his international network and expertise. His contribution has been particularly valuable to Crescent Star Foods Pvt. Ltd., a subsidiary of CSIL, where his knowledge of the global food services market and equipment sourcing has helped strengthen business operations and growth opportunities.

    At CSIL, Mr. Malik brings his entrepreneurial insight, international exposure, and marketing acumen to the Board, supporting the company's strategy of diversification and expansion through its subsidiaries.

    MRS. RABIA OMAR HASSAN

    Director - SINCE 2023

    Ms. Rabia Omar Hassan is a highly accomplished professional with around 25 years of experience in the financial sector, combining deep technical knowledge with creative problem-solving skills. She holds a Master's degree in Economics from the University of Karachi and is currently pursuing her PhD at Liberty University, Virginia, where her research and publications focus on International Criminal Justice.

    Her career spans multiple segments of the financial industry, including private equity facilitation, blue-chip investment advisory, wealth and asset management, and retail, commercial, and corporate banking. She has also gained extensive expertise in liability and cash management, payment services, and asset relationship management.

    At CSIL, Ms. Hassan brings her strong academic foundation, investment experience, and financial markets expertise to the Board, contributing to strategic decision-making and governance with a focus on innovation, discipline, and long-term value creation.

    PROFILE OF THE COMPANY

    Crescent Star Insurance Limited (CSIL), a name synonymous with trust, transformation, and tenacity in Pakistan's insurance and investment landscape. Established in 1957, Crescent Star Insurance Limited (CSI) is a registered insurer with the Securities & Exchange Commission of Pakistan with a paid up capital of PKR 1,077 million. The

    company is listed on the Pakistan Stock Exchange. It is also a member of Insurance Association of Pakistan (IAP).

    CSIL provides both individuals and businesses with a variety of insurance products viz. Travel, Guarantees, Motor, Health, Fire, Marine, Engineering etc. Our focused insurance model is built on sound risk management, emphasizing safe, classes of business such as travel and guarantees.

    The Company has taken the initiative of digitization of its products.

    The Company's CEO Mr. Nairn Anwar brings with him over 40 years of professional experience, including three decades in the insurance industry where he has held several senior leadership roles across sales, operations, reinsurance, underwriting & claims, risk management, and corporate affairs.

    CSIL reflects diversity at its core-with a 50/50 gender-balanced Board, reflecting our commitment to inclusive leadership and modern governance. Our experienced and passionate management team is dedicated to providing personalized insurance solutions with honesty, transparency, and care.

    Our focus remains clear: to deliver value through transparency, to build trust through integrity, and to grow through innovation.

  3. DETAILS OF THE ISSUER

    FINANCIAL DETAILS OF THE ISSUER:

    1. Financial highlights of Issuer for last three years

      Description

      31-Dec-24

      31-Dec-23

      31-Dec-22

      Name of Statutory Auditor

      Crowe Hussain

      Chaudhury & Co.

      Crowe Hussain

      Chaudhury & Co.

      Crowe Hussain

      Chaudhury & Co.

      Net Insurance premium

      224,369,263

      277,821,497

      118,287,466

      Underwriting profit/ (loss)

      67,479,257

      650,500

      (35,013,524)

      Profit before interest & Tax

      94,793,053

      39,741,574

      35,674,621

      Profit after tax

      87,158,719

      68,103,151

      26,932,992

      Total Comprehensive income

      85,50g,659

      74,236,551

      30,815,420

      Description

      31-Dec-24

      31-Dec-23

      31-Dec-22

      Accumulated profit / (loss)

      391,862,675

      306,354,015

      232,117,464

      Total Assets

      1,522,523,739

      1,588,442,027

      1,467,091,466

      Total Liabilities

      253,360,654

      404,787,602

      357,673,592

      Net Equity

      877,300,410

      877,300,410

      877,300,410

      Breakup value per share

      11.78

      10.99

      10.30

      Earnings per share

      0.81

      0.63

      0.25

      Dividend

      31-Dec-24

      31-Dec-23

      31-Dec-22

      As stated in note 8.1 to the

      financial statements, the Company has recorded accrued

      As stated in note 8.1 to the

      financial statements, the Company has recorded accrued

      As stated in note 8.1 to the

      unconsolidated financial statements, the Company has

      Basis for Qualified Opinion and Directors Response

      interest amounting to Rs.

      330.23S million (2023: Rs. 330.235 million) at the rate of one-year KIBOR plus three percent on the advance against issuance of shares to Dost Steels Limited. We have not been provided any documentary evidence to substantiate the Company's claim therefore recoverability of the accrued interest income could not be ascertained. Accordingly, total assets / solvency of the Company is overstated by Rs.330.235 million (2023: Rs.330.235 million) respectively.

      interest amounting to Rs.

      330.235 million (2022: Rs. 310.639 million) at the rate of one-year KiBOR plus three percent on the advance against issuance of shares to Dost Steels Limited. We have not been provided any documentary evidence to substantiate the Company's claim therefore recoverability of the accrued interest income could not be ascertained. Accordingly, profit before tax and total assets / solvency of the Company are overstated by Rs. 19.596 million (2022: Rs. 63.264 million) and

      Rs. 330.235 million (2022: Rs.

      310.639 million) respectively.

      recorded accrued interest

      amounting to Rs. 310.639 million (2021: Rs. 247.374 million) at the rate of one-year KIBOR plus three percent on the advance against issuance of shares to Dost Steels Limited. We have not been provided any documentary evidence to substantiate the Company's claim therefore recoverability of the accrued interest income could not be ascertained. Accordingly, profit before tax and total assets / solvency of the Company are overstated by Rs. 63.265 million (2021: Rs.

      41.267 million) and Rs. 310.639

      million (2021: Rs. 247.374 million) respectively.

      As stated in note 8.2 to the

      financial statements, the Company's carrying value of receivables on account of advance against issuance of shares amounts to Rs. 86.374 million (2023: Rs.82.467 million). The management has not carried nut impairment testing as required by IAS - 36 "lrrtpairment of Assets". No provision for loss, if any, that may result, has been incorporated in the financial statements.

      As stated in note 8.2 to the

      financial statements, the Company's carrying value of receivables on account of advance against issuance of shares amounts to Rs. 82.467 million (2022: Rs. 80.157 million). The management has not carried out impairment testing as required by IAS - 36 "Impairment of Assets". No provision for loss, if any, that may result, has been incorporated in the financial statements.

      As stated in note 8.2 to the

      unconsolidated financial statements, the Company's' carrying value of receivables on account of advance against issuance of shares amounts to Rs. 80.157 million (2021: Rs.

      79.608 million). The management has not carried out impairment testing as required by IAS - 36 "Impairment of Assets". No provision for loss, if any, that may result, has been incorporated in the unconsolidated financial statements.

    2. Financial highlights for the preceding year of consolidated financial:

      Description

      Name of Statutory Auditor

      Net Insurance premium Underwriting profit/ (loss)

      31-Dec-24

      Crowe Hussain Chaudhury & Co.

      224,369,263

      67,479,2S7

      Profit before interest & Tax 41,691,911

      Profit after tax 33,699,865

      Total Comprehensive income

      32,049,80S

      Accumulated profit / (loss)

      (105,140,434)

      Total Assets

      1,121,443,873

      Total Liabilities

      349,283,897

      Net Equity

      877,300,410

      Breakup value per share

      7.16

      Earnings per share

      0.31

      Dividend

    3. Detail of issue of capital in previous five years:

      NIL

    4. Average market price of the share of the Issuer during the last six months: PKR 5.09/- per share observed from *July 2025 to December 2025.

    5. Share Capital and Related Matters (as at December 31, 2025)

      1. Pattern of shareholding of the issuer in both relative and absolute terms.

        Pattern of Shareholding as at December 31, 2025





        Directors & Spouses & Executives

        Mr. Shaikh Waqar Ahmed 1 2,000 0.00%

        Mr. Rashid Malik 1 2,000 0.00%

        Mr. Shail Elahi 1 2,000 0.00%

        Ms. Naveeda Mahmud 1 2,000 0.00%

        Ms. Huma Javaid 1 2,000 0.00%

        Ms. Rabia Omer Hassan 1 3,000 0.00%

        Ms. Komal Sajid Lodhi 1 2,000 0.00%



        Chief Executive Officer

        Mr. Nairn Anwar 1 390,500 0.36%

        Associate Companies, Undertakings & Related Parties - 0.00%

        NIT and ICP "" 0.00/0





        Banks, DFIs and NBFIs 0.00%



        Public Sector Companies and Corporations - 0.00X,

        Insurance Companies

        1 9,224 t 0.01%

        daraba - 0.00%

        Mutual Funds

        0.00%



        General Public

        Local (Individuals) 2,764 82,480,671 76.S9%

        I Foreign Companies / Organizations / Individuals t 1 1,500.00 0.00%







        Others

        Joint Stock Companies 26 23,522,034 21.84%

        Pension Fund, Provident Fund, Trusts 3 1,276,112 1.18%

        2,803 107,695,041 100.00%



        Shareholders Holding 5P» or More Voting Interest

        Weavers Pakistan (Private) Limited 1 t 8,121,477 t 7.54%

        0 FFER DOCUI*IENT | C RESC ENT STAR INSURANC E LI I*IITED



      2. Number of shares held by the directors, sponsors & substantial shareholders of the Issuer (both existing and post right issue).

        Shares Held

        - Existing

        Percentage -Existing

        Shares Held -Post Right lssue

        Percentage Post Right

        Issue

        Sponsors, Directors, CEO their Spouses and Minor Children

        Mr. Shaikh Waqar Ahmed

        2,000

        0.00P»

        2,000

        0.OOH»

        Mr. Rashid Malik

        2,000

        0.00%

        2,000

        0.00%

        Mr. Suhail Elahi

        2,000

        0.00%

        2,000

        0.00'»

        Ms. Naveeda Mahmud

        2,000

        0.OOH»

        2,000

        0.OOH

        Ms. Huma Javaid

        2,000

        0.00%

        2,000

        0.00%

        Ms. Rabia Omer Hassan

        3,000

        0.00%

        3,000

        0.00%

        Ms. Komal Sajid Lodhi

        2,000

        0.00P«

        2,000

        0.00%

        Nairn Anwar

        390,S00

        0.36P»

        390,500

        0.26P»

        Weavers Pakistan (Pvt.) Ltd.

        8,121,477

        7.54'»

        12,384,368

        8.33P»

        Elahi Noor Enterprises (Pvt.) Ltd.

        349,697

        0.32P«

        349,697

        0.24%

        Hina Saleem

        528,000

        0.49P»

        528,000

        0.36P»

        KM Enterprises (Pvt.) Ltd.

        234,966

        0.22P«

        234,966

        0.16%

        Muhammad Ali

        1,578,SOO

        1.47%

        1,57g,500

        1.06%

        Grand Total

        11,218,140

        10.42%

        15,481,031

        10.42'»

      3. Details and shareholding of the holding company, if any. None

    ui)

    Group structure along with respective shareholding in subsidiaries and associates

    Subsidiaries

    Name of Subsidiary

    Shareholding in Subsidiary

    Crescent Star Foods (Pvt.) Limited

    21,305,176 (71%)

    Crescent Star Technologies (Pvt.) Limited

    997 (99%)

    Crescent Star Luxury (Pvt.) Limited

    997 (99%)

    Risk Associated with the rights issue

    A. Under-subscription Risk

  4. RISK FACTORS

    There is a risk that the Right lssue may get undersubscribed due to lack of interest from shareholders of the Company. The Right Issue is being carried out at a price which is less than the current share price in the market and hence there is no major investment risk associated with the Right Issue. The substantial shareholders and directors of the Company have confirmed that they shall subscribe to or arrange the subscription of their respective right entitlements, while the balance portion of the Right Issue will be underwritten in accordance with the applicable laws.

    Page 19

    •• ‹›

    O F F E R DO C U I'•I E N T | C R ESC E NT STAR INSURANCE L I I'•I 1T E D



Risk Associated with the issuer

  1. Internal Risk Factors

    1. Insurance Risk

      The Company accepts the insurance risk through its insurance contracts where it assumes the risk of loss from persons or organizations that are directly subject to the underlying loss. The Company is exposed to the uncertainty surrounding the timing, frequency and severity of claims under these contracts.

      The Company manages its risk via its underwriting and reinsurance strategy within an overall risk management framework. Exposures are managed by having documented underwriting limits and criteria. Reinsurance is purchased where necessary to mitigate the effect of potential loss to the Company'from individual large or catastrophic events and also to provide access to specialist risks and to assist in managing capital.

      A concentration of risk may also arise from a single insurance contract issued to a particular demographic type of policy holder, within a geographical location or to types of commercial business. The Company minimizes its exposure by prudent underwriting and reinsuring policies where necessary.

    2. Credit Risk

      Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company attempts to control credit risk by monitoring credit exposures by undertaking transactions with a large number of counterparties in various industries and by continually assessing the credit worthiness of counterparties.

      Concentration of credit risk occurs when a number of counterparties have a similar type of business activities. As a result, any change in economic, political or other conditions would effect their ability to meet contractual obligations in similar manner. The Company's credit risk exposure is not significantly different from that reflected in the financial statements. The management monitors and limits the Company's exposure to credit risk through monitoring of client's exposure and conservative estimates of provisions for doubtful assets, if any. The management is of the view that it is not exposed to significant concentration of credit risk as its financial assets are adequately diversified in entities of sound financial standing, covering various industrial sectors.

      The Company is exposed to credit risk from its operating activities primarily for premiums due but unpaid, amount due from other insurers/reinsurers, reinsurance recoveries against outstanding claims and other financial assets.

    3. Liquidity Risk

      Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. Prudent liquidity risk management implies maintaining sufficient cash and marketable securities. The Company is financing its operations mainly through equity, working capital and musharaka to minimize risk.

    4. T'echnology and Cyber Risk

      As the company advances into digital age there is cost of software up gradation as well as risks of cyber attacks. The company has taken adequate measures for cyber attacks.

    5. Disclaimer

      Investment risk is borne solely by investors per SECP Circular No. 11 of 2018.

      Page 20

      OFFER DOC U I'•i E N T | C RE SCENT STA R I N SURA NCE LI I•1 IT E D



    1. External Risk Factors

      1. Market Risk

        1. Market risk means that the fair value or future cash flows of financial instrument will fluctuate because of changes in market prices. The objective is to manage and control market risk exposures within acceptable parameters, while optimizing the return. The market risks associated with the Company's business activities are interest / mark up rate risk and price risk. The Company is not exposed to material currency risk.

        2. The company has significant investments in equity shares of listed companies which price is quoted on PSX board and are subject to market forces.

      2. Interest Rate Risk

        Interest/mark-up rate risk is the risk that value of a financial instrument or future cash flows of a financial instrument will fluctuate due to changes in the market interest/mark-up rates. Sensitivity to interest / mark up rate risk arises from mismatches of financial assets and liabilities that mature in a given period.

      3. Foreign Exchange Risk

        Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. Foreign currency risk arises from future commercial transactions or receivables and payables that exist due to transactions in foreign currencies mainly treaty reinsurance contracts.

      4. Risk in the Global Economic and Financial Markets

        Due to ongoing geopolitical disruption causing disruption in international trade, the ripple down effect may affect the Pakistani economy and financial markets adversely which could impact the overall macro condition of the Country. Further government inability to secure new debt from international markets, could affect the PKR/USD parity.

        1. Confirmation Statement

          We the undersigned of Crescent Star insurance Limited certify and hereby solemnly affirm and state that whatever is stated above and in the corresponding annexures with respect to the risk factors associated with the proposed rights issue is true and correct to the best of our knowledge and belief and nothing has been concealed thereto Director

  1. LEGAL PROCEEDINGS

    1. Outstanding Legal Proceedings of the Company

      There are no outstanding legal proceedings other than in the normal course of business involving the issuer, its sponsors, substantial shareholders, directors and associated companies that could have a material impact on the company.

    2. Action taken by the Securities Exchange against the issuer or associated listed companies of

      the issuer during the last three years due to noncompliance of the its Regulations

      1. Appeal pending before IHC against Appellate Bench Order dated 25-09-2024 imposing penalty of PKR 310,000

      2. Appeal pending before IHC against Appellate Bench Order dated 30-09-2024 imposing penalty of PKR 200,000

      3. Appeal pending before the Appellate Bench Order dated 3-03-2025 imposing penalty of PKR 500,000

        Page 21

        OF FER DOC UNENT | C RESC ENT STAR INSURANC E LII'd ITED



    1. Appeal pending before IHC against Appellate Bench Order dated 19-09-2025 imposing penalty of PKR penalty 500,000

    2. Appeal pending before IHC against Appellate Bench Order dated 18-10-2025 imposing penalty of PKR 1,500,000

    3. Appeal pending before IHC against Appellate Bench Order dated 28-10-2025 imposing penalty of PKR 200,000

    4. Appeal pending before IHC against Appellate Bench Order dated 4-12-2025 imposing penalty of PKE 500,000

  1. Any outstanding legal proceeding other than the normal course of business involving the Issuer, its sponsors, substantial shareholders, directors and associated companies, over which the issuer has control, that could have material impact on the issue

These are routine litigations incidental to the business operations, to which the Company is a party that may have a material impact on the Company. Moreover, these litigation matters have already been disclosed in the audited financial statements for the year ended December 31, 2024 and may be referred to for further details in Note No. 17.

The Company is defendant in following:

O The Company filed a petition No. 1027/2022 against Federal Board of Revenue (FBR) in respect encashment of guarantee given for the duties and taxes under Afghan Transit Rules amounting to PKR 26 million. The Custom authorities claim that there was pilferage and the goods did not cross Afghan border. The company stand is that the primary responsibility for pilferage is on the bonded carrier. The High Court has granted stay against the notice of encashment.

O Phillip Morris (Pakistan) Limited has filed suit 33/2021 against the Company for encashment of bond given amounting to PKR 100 million. The party on whose behalf the bond was given has obtained stay order against encashment of guarantee. Further the company is secured by counter guarantee and cheque in respect of the bond amount.

O Suit 6/2022 has been filed by the legal heirs of insured Farzana Akhlaq in relation to travel policy amounting to PKR 11 million. The suit was filed against Company's repudiation of the travel claim on the grounds of pre-existing condition. As per terms of policy pre-existing conditions were not covered.

O Suit 1036/2019 was filed by Pakistan Reinsurance Company Limited for recovery of outstanding amount against CSIL amounting to PKR 75 million. The amount claimed by Pakistan Reinsurance is disputed by the Company.

O The Company is defending various law suits in the court of law. In these cases, claims against the company amounted to less than Rs.10 million. The Company, based on the opinion of its legal advisors, is confident that the ultimate outcome of all of the matters provided above will be in its favor, Accordingly, no provision in respect of any above mentioned liabilities has been made in these financial statements.

irector



O The Sindh Revenue Board (SRB) order has served a demand for PKR 19,485,132 including penalty an Sales Tax on Reinsurance ceded. The matter is disputed and several companies have filed petitions in Supreme Court. The management has filed an appeal against this order.



  1. SIGNATORIES TO THE OFFER DOCUMENT

Chief Executive & Director

Page 22

-

-

OF FE R DOCUI*IENT | C RESC ENT STAR INSURANC E LII*IITED



Disclosure in tabular form of PSX Comments on the Offer Document - Crescent Star Insurance Limited

In compliance with Regulation 3(3)(v) of the Companies (Further Issue of Shares) Regulations, 2020, Crescent Star Insurance Limited had made public disclosure of its Offer Document. We hereby confirm that no comments were received by the SECP on the Offer Document. Observations/Suggestions received from the Pakistan Stock Exchange were adequately addressed and incorporated in the Final Offer Document attached.

S. No

PSX Comment

Response

1.

Ensure final confirmation of dates in coordination with PSX and

SECP before dispatch to shareholders.

Dates confirmed with PSX

2.

Confirm inclusion of two directors' signatures on the final Letter

of offer. Retain signed originals for SECP verification

Added second Directors' signature on the

Offer document

3.

File a copy of the Offer Document with the Registrar

simultaneously with Shareholder dispatch.

Offer Document will be filed with

Registrar simultaneously with shareholders dispatch

4.

Attach a Board certified declaration confirming that no regulatory

actions or penalties have been imposed. Additionally, provide complete details of any past regulatory actions or penalties to avoid resistance during the right issue process

Disclosure of penalties and regulatory

actions taken by SECP disclosed

5.

Update placeholders with final dates before submission. Maintain

dated compliance record summarizing all SECP/PSX communications.

Final dates confirmed with PSX. SECP/PSX

communication record is being maintained

6.

Deposit proceeds in a designated bank account monitored by the

Audit Committee with biannual auditor review. Provide detailed breakup under Principal Purpose of Issue, covering three utilization heads: working capital with details, marketing expenses and digitization of insurance products.

The entire Right Proceeds will be used for

Working Capital related to expand the insurance business of the company including marketing and digitization of insurance products. Quantifying amounts under marketing and digitization at this time is not possible.

7.

Attach SECP registration certificate of the underwriter. Confirm

underwriting covers entire unsubscribed portion of the issue.

SECP registration certificate of

underwriter attached. The underwriting covers the entire amount being offered to general public.

8.

Update shareholder table with committed shares, subscription

values, and pre-/post-issue holdings. Obtain written undertakings confirming full subscription to entitlements.

Undertaking taken from Weavers Pakistan

(Pvt.) Ltd. for subscription to their entitlement.

9.

Clarify the mechanism for fractional shares in the final Offer

Document. Specify timeline for distribution of proceeds to ensure clarity & transparency.

Timeline for distribution of proceeds of

fractional shares incorporated in the Final Offer Document

10.

Include disclaimer that investment risk is borne solely by

investors per SECP Circular No. 11 of 2018.

Incorporated in the Final Offer Document

11.

Attach Board declaration confirming no material litigation on

contingent liabilities. Additionally, provide complete details of any ongoing legal on past regulatory actions or penalties to avoid any resistance during the right issue process.

Pending litigation/contingent liabilities as

disclosed in the financials disclosed in the Final Offer Document

Page 23

« ›•

(OF FER DOC UNENT | CRESC ENT STAR INSURANC E LII*IITED



Disclosure in tabular form of SECP Comments on the Offer Document - Crescent Star Insurance Limited

In compliance with Regulation 3(3)(v) of the Companies (Further Issue of Shares) Regulations, 2020, Crescent Star Insurance Limited had made public disclosure of its Offer Document. Observations/Suggestions received from the SECP were adequately addressed and incorporated in the Final Offer Document attached.

S.No

SECP Comment

Response

1.

General Comments:

Review the entire document for grammatical accuracy.

Reviewed

2

Cover Page

Mention all the missing dates throughout the offer document before publicatiOn

Dates as confirmed by PSX inserted in the Offer Document

3

Undertaking by Board of Directors

Align the Board of Directors undertaking with the contents given in Schedule l.- Undertaking by the Board of Directors.

Aligned with Schedule-I

4

Brief terms of the Rights lssue

  1. Write the serial number of each point

  2. In "basis of determination of price of the right shares" - provide the details of price determination, and remove the expression "the issue price is justified at par value" as the issue price is not at par.

  3. In "date of meeting of BOD wherein the right issue was approved" align the date with point no. 10 of Undertaking by Board of Directors or vice versa.

Serial number added.

Basis of determination of price of the right shares added and correction made.

Date of meeting for approval of Right added as stated in undertaking.

5

Principle Purpose of the lssue and funding arrangements

  1. point A - Activities that are classified as working capital: Provide complete list of activities that are classified as working capital by the Company.

  2. point B - Basis of estimation of working capital requirement: Provide estimated allocation of right issue proceeds under each activity of the working capital and assumption taken thereunder.

  3. point E - Cash conversion cycle: Provide cash conversion cycle days of last 3 years along with the basis of calculation of the same.

a, Activities classified as working capital

defined.

b. Note added.

C Cash Conversion cycle not applicable deleted.

6

Total Expenses to the Issue

  1. Disclose thenames of financial advisor and legal advisor

Legal advisor name added

7

Commitments from substantial shareholders/directors

  1. Provide the disclosure that Weavers Pakistan (Pvt.) Ltd. shall subscribe the unsubscribed portion of directors and promoters or disclose undertaking of all directors and substantial shareholders to subscribe the right issue.

  2. Remove the status of "Substantial Shareholder" from the name of Weavers Pakistan (Pvt.) Limited, as the Company

  1. Note added

  2. Status of Weavers Pakistan (Pvt.) Ltd. amended.

  3. Shareholding of substantial shareholder aligned with number of shares held by the directors, sponsors & substantial

Page 24

OFFER DOCUI*IEN"^I C RESC ENT STAR INSURANCE LI I'•IITED



currently holds less than 10% shares i.e., 6.61%.

iii. Align the shareholding of substantial shareholder in Section

1.6 with Section 4.5 of the Offer Document.

shareholders of the Issuer (both

existing and post right issue).

8

Financial Effects arising from Right Issue

  1. Provide in footnote the date of approval of authorized capital from 115 million to 150 million shares.

  2. Disclose the details that shares are issued at discount and date of approval of discount from the Commission.

Footnote added

Approval date for issuance of shares at discount from Commission added.

9

Financial highlights of the Company

  1. In section 4.2 Disclose the name of the auditor in last 3 years

  2. Disclose the auditor opinion and basis of qualified opinion in the last 3 years

  3. In section 4.3 disclose the average market price of recent six months

  4. In section 4.5 disclose the 100% pattern of shareholding in both absolute and relative terms

  5. In section 4.5 disclose the number of shares held by the directors, sponsors and substantial shareholders of the issuer (both existing and post right issue)

  6. In section 4.5 provide group structure along with names and respective shareholding in subsidiaries and associates.

Auditor name added

i Auditors qualified opinion for last three years disclosed.

Average market price disclosed.

  1. Pattern of shareholding in relative and absolute terms disclosed.

  2. Number of shares held by directors, sponsors, substantial shareholders disclosed.

Group structure with respective shareholding in subsidiaries and associates disclosed.

10

Risk Factors

  1. Section 5.2 Internal Risk Factors:

    1. Operational Risk: describe the operational risks the Company is facing and the mitigation plan, if any.

    2. Liquidity Risk: describe the factors that may contribute to the liquidity risk and mitigation plan, if any.

    3. The Company has significant investments in equity shares and mutual funds, therefore describe the market risk for the Company, and mitigation plan for the risk.

    4. Exchange Risk: Describe how the fluctuations in Foreign exchange rates may directly or indirectly impact the Company.

    5. Describe the "technology and cyber risk", how it may impact the Company and current arrangements in the Company to mitigate this risk.

    6. "underwriting and claims risk" is one of the fundamental risks for non-life insurer. It arises if premiums charged are insufficient relative to expected and actual claims. Describe this risk from Company's perspective and how the Company mitigates it.

    7. "Concentration risk" identifies the over-exposure to a particular class or region. Describe the risk and how the Company has arranged to mitigate it.

  1. Being an insurance company operational Risks have been described under Insurance Risk.

  2. Factors contributing to liquidity risks described.

  3. Market risk for investments in listed equities and mitigation plan described.

  4. Risk to fluctuation in exchange rates described.

  5. Technology and Cyber Risk described.

Underwriting and Claim Risk are described under Insurance Risks.

g. Concentration risks are described under Insurance Risks.

Page 25

O F F E R D O C U I'•I E N T | C R E S C E N T STA R I N S U RA N C E L I H IT E D



11

Legal Proceedings

Legal proceedings of the company: provide brief description of the cases against the Company, as disclosed in the note 17 Ot the Financial Statements for the year ended December 31, 2024.

Routine legal proceedings to incidental to the business operations to which company is a party have been provided.

12.

Signatories to the offer document

Final OD shall be signed by all the relevant signatories.

Final Offer documents will be signed by the CEO and one Director.

Page 26

Earlier from Crescent Star Insurance

All Crescent Star Insurance news releases